Pure Global

B-type Natriuretic Peptide (B-type Natriuretic Peptide ) - India CDSCO Medical Device Registration

B-type Natriuretic Peptide (B-type Natriuretic Peptide ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000104_d38a125e54cc8863f479162a05169557_14607758a2898bf4618b1b5350aabe74. This device is marketed under the brand name CLIA. The license holder is M/s. Peerless Biotech Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
B-type Natriuretic Peptide (B-type Natriuretic Peptide )
UID: IMP/IVD/2023/000104_d38a125e54cc8863f479162a05169557_14607758a2898bf4618b1b5350aabe74

Brand Name

CLIA

Device Class

Class C

Approving Authority

CDSCO

Product Information

B-type Natriuretic Peptide (CLIA) is a Chemiluminescence Immunoassay test for the quantitative measurement of B- type natriuretic peptide (CLIA) in human anticoagulated whole blood and plasma, which is intended as an aid to diagnosis of heart failure. The assay can be used for samples over the range of 15pg/mL~5000pg/mL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing